A systematic review of abatacept and belatacept in immune-mediated diseases
Alissa M. Krek, Dennis D. Arnold, A Martin, Miro E. Raeber
0 citationsJournal of Autoimmunity
A Martin
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
5Publications signalées
63Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
T-cell and B-cell ImmunologySystemic Lupus Erythematosus ResearchChronic Lymphocytic Leukemia ResearchRheumatoid Arthritis Research and TherapiesPsoriasis: Treatment and Pathogenesis
Publications récentes
Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics
Miro E; https://orcid.org/0000-0003-2609-0246 Raeber, Dominic Caspar, Yves; https://orcid.org/0000-0001-5387-9950 Zurbuchen, Nannan Guo et autres
1 citationZurich Open Repository and Archive (University of Zurich)
Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics
Miro E. Raeber, Dominic Caspar, Yves Zurbuchen, Nannan Guo et autres
62 citationsImmunity
Chronic lymphocytic leukemia induced nurse-like cells provide an alternative source of CCL21 for B cells retention within disjointed lymph nodes. Annual Meeting of the French Society for Immunology
R. Zaaboub, L Vimeaux, Vincent Contremoulins, F Cymbalista et autres
0 citationsHAL (Le Centre pour la Communication Scientifique Directe)
Chronic lymphocytic leukemia nurse-like cells are an alternative source of CCL21 homeostatic chemokine in disorganized lymph nodes
R. Zaaboub, Vincent Contremoulins, F Cymbalista, V Levy et autres
0 citationsHAL (Le Centre pour la Communication Scientifique Directe)
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.